BiotechTube

ETC-1002

Phase 1Completed
0 watching 0 views this week๐Ÿ’ค Quiet
28
Hype Score

Development Stage

โœ“
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Safety Evaluation of Escalating Doses

Conditions

Safety Evaluation of Escalating Doses

Trial Timeline

Oct 25, 2011 โ†’ Jan 25, 2012

NCT ID
NCT01485146

About ETC-1002

ETC-1002 is a phase 1 stage product being developed by Esperion Therapeutics for Safety Evaluation of Escalating Doses. The current trial status is completed. This product is registered under clinical trial identifier NCT01485146. Target conditions include Safety Evaluation of Escalating Doses.

Hype Score Breakdown

Clinical
10
Activity
5
Company
5
Novelty
3
Community
2

Clinical Trials (1)

NCT IDPhaseStatus
NCT01485146Phase 1Completed

Competing Products

20 competing products in Safety Evaluation of Escalating Doses

See all competitors
ProductCompanyStageHype Score
LPH-5 + PlaceboBiotrialPhase 1
25
DS-1971 + placeboDaiichi SankyoPhase 1
33
ASP7962 + PlaceboAstellas PharmaPhase 1
33
ASP2151 + Valacyclovir + PlaceboAstellas PharmaPhase 1
33
AZD7986, oral solution, 1 to 50 mg/mL + Placebo, oral solutionAstraZenecaPhase 1
33
Anifrolumab SC injection (300mg) + Anifrolumab IV infusion (300mg) + Anifrolumab SC infusion (600mg) + Anifrolumab placebo SC injection (300mg) + Anifrolumab placebo IV infusion (300mg) + Anifrolumab placebo SC infusion (600mg)AstraZenecaPhase 1
33
AZD7594 + Placebo to matchAstraZenecaPhase 1
33
Anastrozole ODF + Arimidex tablet + Anastrozole ODF + Arimidex tabletAstraZenecaPhase 1
33
AZD4721 Solution + AZD4721 Placebo + AZD4721 SuspensionAstraZenecaPhase 1
33
AZD9977, oral suspension + Placebo, oral suspension + AZD9977, oral solutionAstraZenecaPhase 1
33
AZD3043AstraZenecaPhase 1
33
AZD8848 + Placebo to match AZD8848AstraZenecaPhase 1
33
AZD9567 Monohydrat + Placebo oral suspension/ Placebo capsule + PrednisoloneAstraZenecaPhase 1
33
AZD7503 + PlaceboAstraZenecaPhase 1
33
Fluad + SalineNovartisApproved
85
TBM100NovartisApproved
85
VIB9600 + PlacebosAmgenPhase 1
32
DenosumabAmgenPhase 3
76
Cadonilimab Combined Albumin-paclitaxel, Cisplatin and FluorouracilAkesoPhase 2
51
HTL0018318 + Placebo oral capsuleNxera PharmaPhase 1
32

Other Products from Esperion Therapeutics

Bempedoic Acid / Ezetimibe Oral Tablet + PlaceboApproved
80
Bempedoic Acid 180 MG Oral Tablet + Bempedoic Acid/Ezetimibe 180 MG-10 MG Oral TabletApproved
80
Bempedoic acid + EzetimibePhase 3
72
bempedoic acidPhase 3
72
Bempedoic Acid + Ezetimibe + PlacebosPhase 3
72